164 related articles for article (PubMed ID: 21456169)
1. Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines.
Pandelidou M; Dimas K; Georgopoulos A; Hatziantoniou S; Demetzos C
J Nanosci Nanotechnol; 2011 Feb; 11(2):1259-66. PubMed ID: 21456169
[TBL] [Abstract][Full Text] [Related]
2. Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro.
Mahmud M; Piwoni A; Filipczak N; Janicka M; Gubernator J
PLoS One; 2016; 11(12):e0167787. PubMed ID: 27936114
[TBL] [Abstract][Full Text] [Related]
3. A novel microfluidic liposomal formulation for the delivery of the SN-38 camptothecin: characterization and in vitro assessment of its cytotoxic effect on two tumor cell lines.
Casadó A; Sagristá ML; Mora M
Int J Nanomedicine; 2018; 13():5301-5320. PubMed ID: 30254436
[TBL] [Abstract][Full Text] [Related]
4. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
Chen C; Johnston TD; Jeon H; Gedaly R; McHugh PP; Burke TG; Ranjan D
Int J Pharm; 2009 Jan; 366(1-2):133-9. PubMed ID: 18840516
[TBL] [Abstract][Full Text] [Related]
5. Design and development of liposomes incorporating a bioactive labdane-type diterpene. In vitro growth inhibiting and cytotoxic activity against human cancer cell lines.
Matsingou C; Dimas K; Demetzos C
Biomed Pharmacother; 2006 May; 60(4):191-9. PubMed ID: 16675195
[TBL] [Abstract][Full Text] [Related]
6. Robust Microfluidic Technology and New Lipid Composition for Fabrication of Curcumin-Loaded Liposomes: Effect on the Anticancer Activity and Safety of Cisplatin.
Hamano N; Böttger R; Lee SE; Yang Y; Kulkarni JA; Ip S; Cullis PR; Li SD
Mol Pharm; 2019 Sep; 16(9):3957-3967. PubMed ID: 31381352
[TBL] [Abstract][Full Text] [Related]
7. A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC): physicochemical characterization and cytotoxic activity against human cancer cell lines.
Papagiannaros A; Hatziantoniou S; Dimas K; Papaioannou GT; Demetzos C
Biomed Pharmacother; 2006 Jan; 60(1):36-42. PubMed ID: 16271845
[TBL] [Abstract][Full Text] [Related]
8. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer.
Li L; Ahmed B; Mehta K; Kurzrock R
Mol Cancer Ther; 2007 Apr; 6(4):1276-82. PubMed ID: 17431105
[TBL] [Abstract][Full Text] [Related]
9. Formulation, development and evaluation of hyaluronic acid-conjugated liposomal nanoparticles loaded with regorafenib and curcumin and their in vitro evaluation on colorectal cancer cell lines.
Shnaikat SG; Shakya AK; Bardaweel SK
Saudi Pharm J; 2024 Jul; 32(7):102099. PubMed ID: 38817822
[TBL] [Abstract][Full Text] [Related]
10. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
11. Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer.
Rahman S; Cao S; Steadman KJ; Wei M; Parekh HS
Drug Deliv; 2012; 19(7):346-53. PubMed ID: 23030405
[TBL] [Abstract][Full Text] [Related]
12. Enhancing Curcumin's therapeutic potential in cancer treatment through ultrasound mediated liposomal delivery.
Radha R; Paul V; Anjum S; Bouakaz A; Pitt WG; Husseini GA
Sci Rep; 2024 May; 14(1):10499. PubMed ID: 38714740
[TBL] [Abstract][Full Text] [Related]
13. Hybrid liposomal PEGylated calix[4]arene systems as drug delivery platforms for curcumin.
Drakalska E; Momekova D; Manolova Y; Budurova D; Momekov G; Genova M; Antonov L; Lambov N; Rangelov S
Int J Pharm; 2014 Sep; 472(1-2):165-74. PubMed ID: 24954662
[TBL] [Abstract][Full Text] [Related]
14. Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes.
Moku G; Gulla SK; Nimmu NV; Khalid S; Chaudhuri A
Biomater Sci; 2016 Apr; 4(4):627-38. PubMed ID: 26806172
[TBL] [Abstract][Full Text] [Related]
15. The suitability of liposomes for the delivery of hydrophobic drugs - A case study with curcumin.
Kolter M; Wittmann M; Köll-Weber M; Süss R
Eur J Pharm Biopharm; 2019 Jul; 140():20-28. PubMed ID: 31015019
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent.
Parise A; Milelli A; Tumiatti V; Minarini A; Neviani P; Zuccari G
Drug Deliv; 2015; 22(5):590-7. PubMed ID: 24286206
[TBL] [Abstract][Full Text] [Related]
17. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy.
Mohanty C; Acharya S; Mohanty AK; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2010 Apr; 5(3):433-49. PubMed ID: 20394536
[TBL] [Abstract][Full Text] [Related]
18. Quercetin-Decorated Curcumin Liposome Design for Cancer Therapy: In-Vitro and In-Vivo Studies.
Ravichandiran V; Masilamani K; Senthilnathan B; Maheshwaran A; Wong TW; Roy P
Curr Drug Deliv; 2017; 14(8):1053-1059. PubMed ID: 27572089
[TBL] [Abstract][Full Text] [Related]
19. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
Erdoğ A; Putra Limasale YD; Keskin D; Tezcaner A; Banerjee S
J Pharm Sci; 2013 Oct; 102(10):3666-77. PubMed ID: 23897281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
